Entrada Therapeutics, Inc. — H-1B Visa Sponsorship
Entrada Therapeutics, Inc. Shows Minimal H-1B Sponsorship Activity
Entrada Therapeutics, Inc. H-1B Visa Sponsorship Summary
| Metric | Value |
|---|---|
| Total H-1B Petitions | 1 |
| Approval Rate | 100% |
| Average Salary | $190,309 |
| Salary Range | $190,309 - $190,309 |
| Top Job Title | Associate Director, Scientific Strategy and Innovation |
| Primary Location | Massachusetts |
Browse by Fiscal Year
About Entrada Therapeutics, Inc.'s H-1B Sponsorship
Entrada Therapeutics, Inc. has filed 1 H-1B visa petitions with a 100.0% approval rate. Entrada Therapeutics, Inc. has sponsored 1 H-1B visa in FY2025. The single sponsorship was for an 'Associate Director, Scientific Strategy and Innovation' role. The company has a very limited H-1B sponsorship history, with only one recorded instance.
Key Insights
- The sole H-1B application was filed for FY2025, indicating recent activity.
- The position sponsored is a senior-level role, suggesting a focus on specialized expertise.
- The sponsorship occurred in Massachusetts (MA), a common hub for biotech and pharmaceutical companies.
- The salary offered for the sponsored position was $190,309.
- The company's limited data suggests it may not be a frequent user of the H-1B program.
- All available data points (f, c, d, w, sa, sm, sn, sx) are 1 or 0, except for the salary, which is a single, high value.
- The single job title indicates a specific need rather than broad recruitment.
Expert Analysis
Peer Comparison: Entrada Therapeutics, Inc. sponsors H-1B visas far less frequently than typical mid-sized companies in the biotech sector.
Negotiation Tip: Given the extremely limited sponsorship history, focus on demonstrating highly specialized skills directly relevant to the 'Associate Director, Scientific Strategy and Innovation' role.
Similar Employers
Filing Statistics
| Total Filings | 1 |
| Certified | 1 |
| Approval Rate | 100% |
| Average Salary | $190,309 |
| Median Salary | $190,309 |
| Salary Range | $190,309 – $190,309 |
| 10th Percentile Salary | $190,309 |
| 25th Percentile Salary | $190,309 |
| 75th Percentile Salary | $190,309 |
| 90th Percentile Salary | $190,309 |
| Industry | Professional & Technical Services (NAICS: 54) |
| Sponsor Grade | C — Score: 71/100 (medium confidence) |
USCIS Petition Outcomes for Entrada Therapeutics, Inc.
Actual H-1B visa petition results from USCIS (FY2015–2023). This shows whether petitions were approved or denied by immigration — separate from DOL labor condition filings above.
| Fiscal Year | Approvals | Denials | Approval Rate |
|---|---|---|---|
| 2020 | 1 | 1 | 50% |
| 2021 | 1 | 0 | 100% |
| 2022 | 6 | 0 | 100% |
Salary Distribution
| 10th Percentile | $76,640 |
| 25th Percentile | $83,000 |
| Median (50th) | $108,680 |
| 75th Percentile | $130,000 |
| 90th Percentile | $155,000 |
| Average | $110,384 |
| Sample Size | 32 |
Prevailing Wage Comparison
Processing Time
Workforce Insights
Filing Trend by Year
| Year | Filings | Avg Salary |
|---|---|---|
| FY2025 | 1 | N/A |
Top Job Titles at Entrada Therapeutics, Inc.
| Job Title | Filings |
|---|---|
| Associate Director, Scientific Strategy and Innovation | 1 |
Work Locations
| State | Filings |
|---|---|
| Massachusetts | 1 |
Visa Classes
Frequently Asked Questions about Entrada Therapeutics, Inc.
Does Entrada Therapeutics, Inc. sponsor H-1B visas?
Yes, Entrada Therapeutics, Inc. actively sponsors H-1B visas. They have filed 1 H-1B petition with a 100.0% approval rate.
What is the average H-1B salary at Entrada Therapeutics, Inc.?
The average H-1B salary at Entrada Therapeutics, Inc. is $190,309, with a median of $190,309. Salaries range from $190,309 to $190,309 across 1 filings.
What is Entrada Therapeutics, Inc.'s H-1B approval rate?
Entrada Therapeutics, Inc.'s H-1B approval rate is 100.0%. Out of 1 total filings, 1 were certified, 0 denied, and 0 withdrawn.
How many H-1B visas does Entrada Therapeutics, Inc. file per year?
Entrada Therapeutics, Inc. has filed H-1B petitions across 1 fiscal years. Recent volumes: FY2025: 1.
What jobs does Entrada Therapeutics, Inc. sponsor H-1B visas for?
The most common H-1B job titles at Entrada Therapeutics, Inc. are: Associate Director, Scientific Strategy and Innovation. The top role, Associate Director, Scientific Strategy and Innovation, accounts for 1 filings.
Where are Entrada Therapeutics, Inc.'s H-1B jobs located?
Entrada Therapeutics, Inc.'s H-1B positions are primarily located in Massachusetts (1 filings).
Is Entrada Therapeutics, Inc. increasing or decreasing H-1B hiring?
Entrada Therapeutics, Inc. has filed 1 H-1B petitions total. Insufficient year-over-year data to determine a trend.
What is Entrada Therapeutics, Inc.'s H-1B denial rate?
Entrada Therapeutics, Inc. has a 0.0% denial rate across 1 filings (0 denied). They have zero denials on record.
What is the salary range for H-1B positions at Entrada Therapeutics, Inc.?
H-1B salaries at Entrada Therapeutics, Inc. range from $190,309 to $190,309. The 25th percentile is $190,309, median is $190,309, and 75th percentile is $190,309.
Is Entrada Therapeutics, Inc. a good H-1B sponsor?
Entrada Therapeutics, Inc. has a 100.0% approval rate with 1 filings. The sole H-1B application was filed for FY2025, indicating recent activity.
How does Entrada Therapeutics, Inc.'s H-1B salary compare to market?
Entrada Therapeutics, Inc. pays an average of $190,309 for H-1B positions. The position sponsored is a senior-level role, suggesting a focus on specialized expertise.
How does Entrada Therapeutics, Inc. compare to Moderna, Inc. for H-1B?
Entrada Therapeutics, Inc. sponsors H-1B visas far less frequently than typical mid-sized companies in the biotech sector.
What should I negotiate for an H-1B position at Entrada Therapeutics, Inc.?
Given the extremely limited sponsorship history, focus on demonstrating highly specialized skills directly relevant to the 'Associate Director, Scientific Strategy and Innovation' role.
What should H-1B candidates know about Entrada Therapeutics, Inc.?
The sponsorship occurred in Massachusetts (MA), a common hub for biotech and pharmaceutical companies.